Search results for: 'm ai a medtech'

This Frost & Sullivan study focuses on sustainability in the MedTech industry and offers a detailed discussion on 2 sustainability programs, Climate Action and Responsible Consumption and Production. The study's focus areas include key regulations in the EU, such as the EUDAMED database and green taxonomy and ESG in the United States and Asia-Pacif...

09 Apr 2024  |  North America  |  Market Research

Global Medtech Outlook, 2024

New Product Development and Approvals Drive Industry Growth Opportunities

Infographics

×

The Global MedTech Outlook, 2024 presents a comprehensive analysis of the global MedTech industry in terms of growth potential and important market dynamics. The analysis covers major MedTech segments such as cardiovascular, orthopedics, patient monitoring, respiratory devices, neurology, diabetes care, and clinical-grade wearables. It highlights k...

The application of Generative AI (Gen AI) in healthcare is a rapidly growing field. In recent years, emerging applications in drug discovery and development, medical imaging analysis, digital twins, synthetic data, and electronic health records management, and virtual assistants have garnered significant interest thanks to their potential to revolu...

Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...

The overall outlook for M&A activity continues to be positive as private equity investment in the space continues to grow at a healthy rate. The industry continues to be fragmented, which in turn provides an incentive to companies to consolidate. Additionally, companies are looking to become one-stop shop providers of PPE. Innovation continues to b...

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...

Although artificial intelligence (AI) has been around for decades, and the contact center industry has been leveraging it for years, recent advancements in AI have rapidly accelerated. The latter half of 2024 spouted industry excitement for next-level GenAI - agentic AI, also sometimes called autonomous AI. Agentic AI can act as the glue for orches...

This Frost & Sullivan market insight presents an overview of the artificial intelligence (AI) initiatives powering the next-generation business support system (BSS) initiatives in the global mobile communications market. It describes the various opportunities that generative AI (Gen AI) supports with the enhancement of existing BSS functions and pr...